Related Experiment Video
Updated: Aug 19, 2026

Evaluation of Drug Sorption to PVC- and Non-PVC-based Tubes in Administration Sets Using a Pump
Published on: March 11, 2017
Managing drugs safely
1George Washington University School of Medicine and Health Sciences, 111 Michigan Avenue NW, Washington, DC 20010, United States. jvandena@cnmc.org
Insights
Newborn infants face higher risks of adverse drug reactions. Legislation now aims to improve pediatric drug safety, necessitating blame-free adverse event reporting and electronic order entry to prevent medication errors.
Area of Science:
- Neonatal pharmacology
- Pediatric drug safety
- Health policy
Background:
- Newborn infants exhibit a higher susceptibility to adverse drug reactions compared to adults.
- Historical drug legislation overlooked neonates until the Best Pharmaceuticals Act for Children in 2002.
- Increased prescribing of licensed drugs for neonates is anticipated.
Purpose of the Study:
- To highlight the critical need for improved drug safety in neonates.
- To advocate for systems that support the analysis of drug-related errors.
- To emphasize the importance of a blame-free environment for reporting adverse drug events.
Main Methods:
- Review of existing data on neonatal adverse drug reactions.
- Analysis of legislative history concerning pediatric drug safety.
- Discussion of potential system improvements for medication safety.
Main Results:
- Neonates are disproportionately affected by adverse drug events.
- The Best Pharmaceuticals Act for Children marked a significant shift in pediatric drug safety policy.
- Systemic improvements are crucial for enhancing medication safety in neonates.
Conclusions:
- Enhanced reporting of adverse drug events in a blame-free setting is essential for neonates.
- Computerized physician order entry systems offer a promising solution to prevent medication errors.
- Proactive measures are required to ensure the safe and effective use of medications in the neonatal population.
Abstract:
There is hard data to show that newborn infants are more likely than adults to experience adverse reactions to drugs. Paradoxically, drug-related legislation to ensure safe and effective drug use in humans neglected neonates until 2002, when the Best Pharmaceuticals Act for Children was signed into law in the USA. The situation for neonates should now catch up with that for adults and neonates will be prescribed more licensed drugs in the near future. If we are to be able to analyze the underlying system errors to improve the safe use of drugs in the studied patient population, reporting of adverse drug events and reactions needs to happen in a blame free environment. In addition, computerized physician order entry will certainly further improve the current situation by preventing errors in ordering, transcribing, verifying, and transmitting medication orders.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Drug Dosing: Geriatric Patients
Drug Classes and Categories
Drug Therapy
Antianxiety Medications
Factors Affecting Drug Response: Overview
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady state,...

